EHT1864 suppressed the ability of the DT13 cells to grow in soft agar as well as MCF7 cells (Supplementary Figure 9), suggesting that breast cancers including those that overexpress HER2 may be susceptible to Rac-targeted therapies. Here, AKT1 is linked to breast cancer.